• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 4, 2021

Assessing the Link Between Sugary Drinks and Cancer

Author(s):

Aminat Awogun, BPharm student

Consumption of sugary drinks regularly may be a major contributory factor to the epidemic of cancer, according to a study published by the British Medical Journal.

Over the past 2 decades, there has been an increase in the consumption of sugar worldwide, partly because of beverage marketing and growing urbanization.1 This lifestyle is deeply rooted in western countries. Data from the United States National Health and Nutrition Examination Survey showed that the intake of sugar in the US population surpassed the recommended calorie intake, with the average intake of men and women aged 18 years and older being 1.5 and 2.8 greater, respectively.2

On average, half of the US population consumes sugary drinks on a given day, with data showing 1 in 4 people get at least 200 calories daily from sugary drinks.3 Consumption of sugary drinks regularly may be a major contributory factor to the epidemic of cancer, according to a study published by the British Medical Journal.4

According to the study, a sugary drink is more than 5% sugar, which includes sugar-sweetened beverages, soft drinks (carbonated or non-carbonated), fruit drinks, sports drinks, energy drinks, and 100% fruit juices. These beverages are the single most significant sources of calories in the United States.5

The study assessed the correlation between the consumption of sugary drinks and artificially sweetened beverages, plus the risk of overall cancer, breast cancer, prostate cancer, and colorectal cancers.

The result of the study found that a 100 mL/day increase in the consumption of sugary drinks is associated with an 18% increased risk of overall cancer and 22% increased risk of breast cancer. Surprisingly, the consumption of 100% fruit juice, despite the natural and overall healthy image in the population, was also significantly associated with the risk of overall cancer. Although the sample study was large, an even larger-scale replication is still required, according to the study authors.

Possible risk factors for cancer, including sex, age, family history of cancer, smoking status, and physical activity level, were taken into consideration; however, the connection between sugary drinks and cancer remained the same.

Sugary drinks promote the accumulation of fats in the visceral area through changes in the adipokine secretion and cell signal pathways. The increased visceral deposit plays a role in the development of cancer, independent of the body weight.

In the study, obesity and weight gain were not the only driving pointers for the association between sugary drinks and cancer. High simple sugar consumption is not only associated with obesity, but is also linked to type 2 diabetes, and insulin resistance, which are positive risk factors for the development of cancer.

Although it is necessary to carefully interpret the study, the findings add to the evidence showing that a reduction in the consumption of sugary drinks decreases the risk of overall cancer. The research team found no correlation between sugary drinks and prostate or colon cancer because few people in the study developed these cancers, making the findings less definitive.

According to the study authors, another possible link between sugar and cancer is the high glycemic index. Several sugary drinks contain advanced glycation end products, which can impair the epithelial function in patients with or without diabetics.

The increase in glycemic index raises postprandial blood glucose, which in turn increases the risk of cancer by stimulating the synthesis of insulin-like growth factor. A high glycemic index is associated with hyperinsulinemia and type 2 diabetes, which are both risk factors for the development of breast cancer.

Furthermore, the research team observed high sugar contents served as the driving link between sugar and cancer, with daily intake of sugar from drinks largely associated with cancer. Sugary drinks with low sugar contents that were consumed in higher amounts were also positively associated with cancer.

In contrast, the research found no link between the risk of cancer and consumption of coffee, artificially sweetened beverages, diet soda, and unsweetened tea.

In addition, sugary drinks contain an additive, 4-methylimidazole, found in drinks that contain caramel coloring, or artificial sweeteners such as aspartame, which may also play a role in carcinogenesis.5

Consuming sugar-sweetened beverages regularly is not healthy, as it is associated with diseases such as heart diseases, diabetes, and obesity. Interestingly, the metabolic alterations caused by the consumption of sugar has also been linked to the development of hepatocellular carcinoma.1

REFERENCES

  • Malik V., Willet W., Hu F. Global obesity: trends, risk factors, and policy implications. Nature Reviews Endocrinology. 2013; 9(1):13.
  • Natasha T., Li J., and Nancy P. Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. International Journal of Cancer. 2012; 130(1): 159-169.
  • Ogden C., Kit B., Caroll M., Park S. Consumption of sugar drinks in the United States. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. 2011.
  • Malik V., Matthas B., Frank B. Intake of sugar-sweetened beverages and weight gain: a systematic review. The American Journal of Clinical Nutrition. 2006; 84(2): 274-288.
  • Eloi C., Bernard S., Elisa D., Mathilde T. et al. Sugary drink consumption and risk of cancer: results from NutriNet- Sante prospective cohort. BMJ, 2019;I2 408 DOI: 10. 1136/bmj.I2408

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue.
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Related Content
Advertisement
Cytokine Protein Signaling: Molecular Segregation by Activated T Helper Cell to Combat Allergy, Asthma, and Fever in Naive Peptide Responses
June 18th 2025

Proinflammatory SARS-CoV-2 Cytokines Higher in Men Than Women, Causing Heightened Rates of Severe Disease

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Precision oncology -- Image credit: Gorodenkoff | stock.adobe.com
June 18th 2025

Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine Oncology Pharmacist

Justin Grahl, PharmD Abigail Beachy, PharmD Islam Elbedewy, PharmD Candidate Megan Mills, PharmD Rachel Schneider, PharmD
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Vector Representation of Acute Myeloid Leukemia Cells
June 18th 2025

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Alan Flores, PharmD Jose Tinajero, PharmD, BCOP Dat Ngo, PharmD
Pneumococcal vaccine in a vial, immunization and treatment of infection
June 18th 2025

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Luke Halpern, Assistant Editor
Related Content
Advertisement
Cytokine Protein Signaling: Molecular Segregation by Activated T Helper Cell to Combat Allergy, Asthma, and Fever in Naive Peptide Responses
June 18th 2025

Proinflammatory SARS-CoV-2 Cytokines Higher in Men Than Women, Causing Heightened Rates of Severe Disease

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Precision oncology -- Image credit: Gorodenkoff | stock.adobe.com
June 18th 2025

Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine Oncology Pharmacist

Justin Grahl, PharmD Abigail Beachy, PharmD Islam Elbedewy, PharmD Candidate Megan Mills, PharmD Rachel Schneider, PharmD
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Vector Representation of Acute Myeloid Leukemia Cells
June 18th 2025

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Alan Flores, PharmD Jose Tinajero, PharmD, BCOP Dat Ngo, PharmD
Pneumococcal vaccine in a vial, immunization and treatment of infection
June 18th 2025

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.